<?xml version="1.0" encoding="UTF-8"?>
<p id="p0055">Thus DNA and mRNA vaccines that are easier to design and proceed into clinical trials very quickly are excellent target for development of vaccines against SARS-CoV 2 and other related outbreaks in future.</p>
